Concepedia

Curt Christoffersen

CC

Statistics

Publications

12

Citations

425

H-Index

11

Active since

1989

Affiliations

Pfizer (United States)(Current)

Zhejiang Hisun Pharmaceutical (China)

Gaertner (United States)

Curt Christoffersen is an author at Pfizer (United States) specializing in pharmacology, neuropharmacology, and neuroscience.

Publications per year

1989–2012

12

Publications

12

Evidence for N-methyl-d-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: Possible preferential role for N-methyl-d-aspartate receptors

Curt Christoffersen, Leonard T. Meltzer · Neuroscience · 1995 · 112 citations

, , +15

Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo

Robin J. Kleiman, Douglas S. Chapin, Curt Christoffersen et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 80 citations

, , +17

Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies To Identify Centrally Efficacious Inhibitors

Michael A. Brodney, Gabriela Barreiro, Kevin Ogilvie et al. · Journal of Medicinal Chemistry · 2012 · 60 citations · Full text

, , +17

Metabotropic glutamate receptor-mediated inhibition and excitation of substantia nigra dopamine neurons

Leonard T. Meltzer, Kevin A. Serpa, Curt Christoffersen · Synapse · 1997 · 33 citations

, , +17

Adverse effects of a SERM (Levormeloxifene)

L. Warming, Curt Christoffersen, B.J. Riis et al. · Maturitas · 2003 · 32 citations

, , +8

1–5 of 12